Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy Volunteers
Status:
Completed
Trial end date:
2002-04-01
Target enrollment:
Participant gender:
Summary
To investigate the pharmacokinetics of a single 900 mg oral dose of BIA 2-093 and a single
900 mg oral dose of Oxcarbazepine in healthy volunteers and to assess the tolerability of a
single 900 mg dose of BIA 2-093 and Oxcarbazepine.